| The Division of Pharmacy at the University of Texas MD Anderson Cancer Center offers a PGY2 Pharmacy Residency in Medication-Use Safety and Policy. MD Anderson is a world renowned 650+ bed acute patient care and 5100+ visit/day outpatient cancer center located in the Texas Medical Center. The residency program provides a broad range of medication use management experiences with an emphasis in drug information including formulary management and implementation, drug shortage management, policy and accreditation, fostering a culture of safety, evaluating and reporting adverse drug reactions and medication errors, and quality improvement. Residents are provided opportunities to develop skills in critical literature evaluation, evidence-based medicine, interdisciplinary committee coordination, and clinical informatics. The program allows for tailored instruction for the individual resident based on interest(s), past experience, and future goals. The PGY2 Pharmacy Residency in Medication-Use Safety and Policy will develop practitioners capable of serving as an expert on drug information and optimal medication use in a hospital/health-system setting. Following completion of the residency, graduates will be prepared for a position in drug information, formulary management, drug shortage management, drug-use policy, medication safety, policy and accreditation, drug utilization, or related role within health system pharmacy. Other information: MD Anderson Cancer Center is an Equal Opportunity Employer The start date for this residency program is early-July The annual stipend for this program is $60,000 PGY2 Medication-Use Safety and Policy resident positions = 1 Visit our website for more information at www.mdanderson.org/pharmacy. Interested candidates should email their CV and request for a PPS interview to Stacey Sobocinski, PharmD, BCPS; Residency Program Director, PGY2 Medication-Use Safety and Policy Pharmacy residency program at PGY2-MUSPResidency@mdanderson.org. |
